{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:01:03Z","timestamp":1753891263093,"version":"3.41.2"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To probe the efficacy of budesonide suspension in treating lobar pneumonia by fiberoptic bronchoscopic alveolar lavage.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 176 preschool and school-age children with lobar pneumonia in the pediatric respiratory department of Binzhou Medical University Hospital from December 2020 to December 2021 were selected and divided into observation group (OG, <jats:italic>n<\/jats:italic>\u202f=\u202f88) and control group (CG, <jats:italic>n<\/jats:italic>\u202f=\u202f88) based on the wishes of their families. Children in both groups were given azithromycin sequential treatment. The CG was given fiberoptic bronchoscope alveolar lavage with sodium chloride injection, and the OG was treated with fiberoptic bronchoscope alveolar lavage with sodium chloride injection + inhalation of budesonide suspension. The treatment, inflammatory factor levels, immune function, lung function indicators, adverse reactions and clinical efficacy were compared between both groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The total effective rate of the OG was 90.91%, which was better than 81.82% of the CG (<jats:italic>\u03c7<\/jats:italic><jats:sup>2<\/jats:sup>\u202f=\u202f3.095, <jats:italic>p<\/jats:italic>\u202f&amp;lt;\u202f0.05). After treatment, the serum IL-6, CRP and ESR levels declined, and IL-2 level was elevated in the OG relative to the CG (<jats:italic>p<\/jats:italic>\u202f&amp;lt;\u202f0.05). The levels of IgM, IgA, IgG, FVC, FEV1, PEF, FEF25, FEF50, FEF75 and FEF25-75 in the OG were enhanced compared to the CG (<jats:italic>p<\/jats:italic>\u202f&amp;lt;\u202f0.05). The antipyrexia time, the disappearance time of lung shadow, the improvement time of cough and expectoration, and the disappearance time of lung rales in the OG were shorter compared to the CG (<jats:italic>p<\/jats:italic>\u202f&amp;lt;\u202f0.05).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Budesonide combined with fiberoptic bronchoscopy lavage in treating lobar pneumonia in children with <jats:italic>Mycoplasma pneumoniae<\/jats:italic> is effective in enhancing the therapeutic effect, relieving the clinical symptoms and signs of children faster, significantly reducing the inflammatory response, and significantly improving lung function. It is safe, effective and has no adverse reactions.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2025.1598234","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T04:10:55Z","timestamp":1750824655000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of budesonide suspension in the treatment of lobar pneumonia by fiberoptic bronchoscopic alveolar lavage"],"prefix":"10.3389","volume":"12","author":[{"given":"Xin","family":"Ji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongjie","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiugui","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinghua","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangqin","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,25]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.3892\/etm.2017.4319","article-title":"Principles of antibiotic application in children with lobar pneumonia: step-up or step-down","volume":"13","author":"Li","year":"2017","journal-title":"Exp Ther Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12879-020-4938-7","article-title":"Epidemiology and clinical characteristics of pathogens positive in hospitalized children with segmental\/lobar pattern pneumonia","volume":"20","author":"Wang","year":"2020","journal-title":"BMC Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"408","DOI":"10.2471\/BLT.07.048769","article-title":"Epidemiology and etiology of childhood pneumonia","volume":"86","author":"Rudan","year":"2008","journal-title":"Bull World Health Organ"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.prrv.2019.06.001","article-title":"Childhood pneumonia in low-and-middle-income countries: an update","volume":"32","author":"Marangu","year":"2019","journal-title":"Paediatr Respir Rev"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"010401","DOI":"10.7189\/jogh.03.010401","article-title":"Epidemiology and etiology of childhood pneumonia in 2010: estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries","volume":"3","author":"Rudan","year":"2013","journal-title":"J Glob Health"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"156","DOI":"10.12669\/pjms.36.2.1441","article-title":"Comparison of azithromycin and erythromycin in the treatment of mycoplasma pneumonia in children","volume":"36","author":"Han","year":"2020","journal-title":"Pak J Med Sci"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3390\/pharmaceutics3010053","article-title":"Factors and mechanisms for pharmacokinetic differences between pediatric population and adults","volume":"3","author":"Fernandez","year":"2011","journal-title":"Pharmaceutics"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s12098-018-2662-8","article-title":"Ventilator associated pneumonia in pediatric intensive care unit: incidence, risk factors and etiological agents","volume":"85","author":"Vijay","year":"2018","journal-title":"Indian J Pediatr"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/j.1365-2125.2005.02445.x","article-title":"How children's responses to drugs differ from adults","volume":"59","author":"Stephenson","year":"2005","journal-title":"Br J Clin Pharmacol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"922","DOI":"10.12669\/pjms.38.4.4835","article-title":"Effect of bronchofiberscopic lavage with budesonide suspension on refractory mycoplasma pneumoniae pneumonia","volume":"38","author":"Li","year":"2022","journal-title":"Pak J Med Sci"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.12669\/pjms.40.7.9495","article-title":"Clinical value of vitamin-D combined with budesonide\/formoterol and theophylline sodium glycinate sustained-release tablets in the treatment of chronic obstructive pulmonary disease patients","volume":"40","author":"Ni","year":"2024","journal-title":"Pak J Med Sci"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"88","DOI":"10.23736\/S0026-4806.21.07609-6","article-title":"Application of fiberoptic bronchoscopy assisted local injection of budesonide in improving the prognosis of severe pneumonia","volume":"115","author":"Tian","year":"2021","journal-title":"Minerva Med"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"010302","DOI":"10.7189\/jogh.03.010302","article-title":"Setting priorities for development of emerging interventions against childhood diarrhoea","volume":"3","author":"Bhutta","year":"2013","journal-title":"J Glob Health"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s40121-023-00914-x","article-title":"Clinical characteristics of lung consolidation with Mycoplasma pneumoniae pneumonia and risk factors for Mycoplasma pneumoniae necrotizing pneumonia in children","volume":"13","author":"Zhang","year":"2024","journal-title":"Infect Dis Ther"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1155\/1995\/174578","article-title":"Fibreoptic bronchoscopy in the diagnosis of pulmonary disease in the immunocompromised host in northern Alberta","volume":"6","author":"Crocket","year":"1995","journal-title":"Can J Infect Dis"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/14787210.2018.1414599","article-title":"Antimicrobial therapy of macrolide-resistant Mycoplasma pneumoniae pneumonia in children","volume":"16","author":"Lee","year":"2018","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S0140-6736(21)01744-X","article-title":"Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial","volume":"398","author":"Yu","year":"2021","journal-title":"Lancet"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S2213-2600(18)30327-8","article-title":"Triple therapy with budesonide\/glycopyrrolate\/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trial","volume":"6","author":"Ferguson","year":"2018","journal-title":"Lancet Respir Med"},{"key":"ref19","first-page":"10517","article-title":"The effects of the atomization inhalation of budesonide, salbutamol, and ipratropium bromide on the T-lymphocyte subset and inflammatory cytokine levels in children with asthmatic pneumonia","volume":"13","author":"Duan","year":"2021","journal-title":"Am J Transl Res"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"861","DOI":"10.2214\/ajr.177.4.1770861","article-title":"Utility of fiberoptic bronchoscopy before bronchial artery embolization for massive hemoptysis","volume":"177","author":"Hsiao","year":"2001","journal-title":"AJR Am J Roentgenol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s13052-022-01376-6","article-title":"Correlation between Mycoplasma pneumoniae drug resistance and clinical characteristics in bronchoalveolar lavage fluid of children with refractory Mycoplasma pneumoniae pneumonia","volume":"48","author":"Zhan","year":"2022","journal-title":"Ital J Pediatr"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1002\/pbc.20784","article-title":"Fiberoptic bronchoscopy and bronchoalveolar lavage for the evaluation of pulmonary disease in children with primary immunodeficiency and cancer","volume":"48","author":"Efrati","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/crj.13620","article-title":"Clinical characteristics and serum inflammatory markers of community-acquired mycoplasma pneumonia in children","volume":"17","author":"Fan","year":"2023","journal-title":"Clin Respir J"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/JLB.2RI0717-278R","article-title":"Biology of IL-2 and its therapeutic modulation: mechanisms and strategies","volume":"103","author":"Mitra","year":"2018","journal-title":"J Leukoc Biol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/PCC.0000000000000976","article-title":"The impact of chronic health conditions on length of stay and mortality in a general PICU","volume":"18","author":"O'Brien","year":"2017","journal-title":"Pediatric Critical Care Med"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"e00471","DOI":"10.1128\/CVI.00471-16","article-title":"Role of serum Mycoplasma pneumoniae IgA, IgM, and IgG in the diagnosis of Mycoplasma pneumoniae-related pneumonia in school-age children and adolescents","volume":"24","author":"Lee","year":"2017","journal-title":"Clin Vaccine Immunol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s11739-011-0517-7","article-title":"The role of Th17 lymphocytes in the autoimmune and chronic inflammatory diseases","volume":"6","author":"Murdaca","year":"2011","journal-title":"Intern Emerg Med"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"4865","DOI":"10.3390\/ijms24054865","article-title":"Th17\/Treg imbalance: implications in lung inflammatory diseases","volume":"24","author":"Thomas","year":"2023","journal-title":"Int J Mol Sci"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/S1875-5364(19)30029-9","article-title":"Astragalus membranaceus improves therapeutic efficacy of asthmatic children by regulating the balance of Treg\/Th17 cells","volume":"17","author":"Wang","year":"2019","journal-title":"Chin J Nat Med"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1016\/j.jaip.2024.05.049","article-title":"Allergic diseases and mental health","volume":"12","author":"Conway","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/6865758","article-title":"Immunoregulatory role of HLA-G in allergic diseases","volume":"2016","author":"Murdaca","year":"2016","journal-title":"J Immunol Res"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1598234\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T04:10:56Z","timestamp":1750824656000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1598234\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,25]]},"references-count":31,"alternative-id":["10.3389\/fmed.2025.1598234"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1598234","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2025,6,25]]},"article-number":"1598234"}}